Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Is electroconvulsive therapy safe in multiple sclerosis?
Physical therapy provision in multiple sclerosis across Europe: a regional lottery?
Assessment of cortical damage in early multiple sclerosis with quantitative T2 relaxometry.
Perceived Impact of a Self-Management Program for Fatigue in Multiple Sclerosis: A Qualitative Study.
OCT and Visual Field Changes as Useful Markers for Follow-up of Axonal Loss in Multiple Sclerosis in Egyptian Patients.
Immunology for understanding the pathogenesis of multiple sclerosis.
Does Natalizumab Therapy Benefit Patients With Multiple Sclerosis?
A case of neuromyelitis optica spectrum disorder associated with central pontine and extrapontine myelinolysis preceded by syndrome of inappropriate antidiuretic hormone secretion.
Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) regulatory T cells in multiple sclerosis.
Thoughts of death and self-harm in patients with epilepsy or multiple sclerosis in a tertiary care center.
Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments.
Medical image. Neuromyelitis optica masquerading as sepsis.
Chemokine biomarkers in central nervous system tissue and cerebrospinal fluid in the Theiler's virus model mirror those in multiple sclerosis.
Understanding fatigue in paediatric multiple sclerosis: a systematic review of clinical and psychosocial factors.
Chronic Peripheral Inflammation, Hippocampal Neurogenesis, and Behavior.
Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice.
GWAS and transcriptional analysis prioritize ITPR1 and CNTN4 for a serum uric acid 3p26 QTL in Mexican Americans.
Functional and structural cerebral changes in key brain regions after a facilitation programme for episodic future thought in relapsing-remitting multiple sclerosis patients.
[Diagnostic criteria for neuromyelitisoptica spectrum disorders].
Caregiving in multiple sclerosis.
Morphologic features of the binucleated lymphocytes for the assesment of persistent B-cell polyclonal lymphocytosis.
Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy.
Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis.
SURF1 deficiency causes demyelinating Charcot-Marie-Tooth disease.
Deep brain stimulation for pain.
Pages
« first
‹ previous
…
683
684
685
686
687
688
689
690
691
…
next ›
last »